Cardioxyl Pharmaceuticals' Acquisition

Cardioxyl Pharmaceuticals was acquired by Bristol-Myers Squibb on November 02, 2015.

Cardioxyl Pharmaceuticals is a privately held, clinical stage biopharmaceutical company developing therapies for the treatment of cardiovascular disease, focusing on the discovery, development and com…

Articles about Cardioxyl Pharmaceuticals' Acquisition: